Abstract
Dopamine eye drops produce marked dilatation of the pupil in man. This mydriatic effect is inhibited by pretreatment with guanethidine. It is therefore concluded that dopamine acts indirectly via adrenergic nerve endings, rather than exerting a direct effect on adrenergic receptors in the dilator pupillae muscle. In this respect dopamine resembles the phenyl-alkylamines, such as tyramine, rather than the catecholamines, adrenaline and noradrenaline.
If dopamine acts by releasing noradrenaline from adrenergic nerve endings, high concentrations of dopamine could lead to depletion of noradrenaline stores, since synthesis might be unable to keep pace with release. This could be the explantion for the orthostatic hypotension found in patients taking L-dopa for Parkinsonism.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calne D. B., Stern G. M., Laurence D. R., Sharkey J., Armitage P. L-dopa in postencephalitic parkinsonism. Lancet. 1969 Apr 12;1(7598):744–746. doi: 10.1016/s0140-6736(69)91751-6. [DOI] [PubMed] [Google Scholar]
- Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
- Crombie A. L., Lawson A. A. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction. Br Med J. 1967 Dec 9;4(5579):592–595. doi: 10.1136/bmj.4.5579.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HARRISON W. H., LEVITT M., UDENFRIEND S. NOREPINEPHRINE SYNTHESIS AND RELEASE IN VIVO MEDIATED BY 3,4-DIHYDROXYPHENETHYLAMINE. J Pharmacol Exp Ther. 1963 Nov;142:157–162. [PubMed] [Google Scholar]
- Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
- OBIANWU H. O., RAND M. J. THE RELATIONSHIP BETWEEN THE MYDRIATIC ACTION OF EPHEDRINE AND THE COLOUR OF THE IRIS. Br J Ophthalmol. 1965 May;49:264–270. doi: 10.1136/bjo.49.5.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sneddon J. M., Turner P. Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet. 1966 Sep 3;2(7462):525–527. doi: 10.1016/s0140-6736(66)92881-9. [DOI] [PubMed] [Google Scholar]
- Sneddon J. M., Turner P. Ephedrine mydriasis in hypertension and the response to treatment. Clin Pharmacol Ther. 1969 Jan-Feb;10(1):64–71. doi: 10.1002/cpt196910164. [DOI] [PubMed] [Google Scholar]
- Turner P., Sneddon J. M. Alpha receptor blockade by thymoxamine in the human eye. Clin Pharmacol Ther. 1968 Jan-Feb;9(1):45–49. doi: 10.1002/cpt19689145. [DOI] [PubMed] [Google Scholar]